Transcriptional mechanisms of acute lung injury.

Acute lung injury occurs as a result of a cascade of cellular events initiated by either infectious or noninfectious inflammatory stimuli. An elevated level of proinflammatory mediators combined with a decreased expression of anti-inflammatory molecules is a critical component of lung inflammation. Expression of proinflammatory genes is regulated by transcriptional mechanisms. Nuclear factor-kappa B (NF-kappa B) is one critical transcription factor required for maximal expression of many cytokines involved in the pathogenesis of acute lung injury. Activation and regulation of NF-kappa B are tightly controlled by a complicated signaling cascade. In acute lung injury caused by infection of bacteria, Toll-like receptors play a central role in initiating the innate immune system and activating NF-kappa B. Anti-inflammatory cytokines such as interleukin-10 and interleukin-13 have been shown to suppress inflammatory processes through inhibiting NF-kappa B activation. NF-kappa B can interact with other transcription factors, and these interactions thereby lead to greater transcriptional selectivity. Modification of transcription is likely to be a logical therapeutic target for acute lung injury.

[1]  W. Shoemaker,et al.  Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury , 1994, Critical care medicine.

[2]  U. Göbel,et al.  Involvement of Lipopolysaccharide Binding Protein, CD14, and Toll-Like Receptors in the Initiation of Innate Immune Responses by Treponema Glycolipids1 , 2000, The Journal of Immunology.

[3]  P. Baeuerle.  Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle? , 1998, Current biology : CB.

[4]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[5]  A. Baldwin,et al.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B , 1993, Molecular and Cellular Biology.

[6]  G. Hunninghake,et al.  Lung inflammation and fibrosis. , 1998, American journal of respiratory and critical care medicine.

[7]  W. Sha.  Regulation of Immune Responses by NF-κB/Rel Transcription Factors , 1998, The Journal of experimental medicine.

[8]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[9]  M. Trush,et al.  Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. , 1998, Biochemical and biophysical research communications.

[10]  C. Farver,et al.  CONSTITUTIVE NF-κB LEVELS IN HUMAN ALVEOLAR MACROPHAGES FROM NORMAL VOLUNTEERS , 1998 .

[11]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[12]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[13]  P. Mehlen,et al.  Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression , 1996, The Journal of cell biology.

[14]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[16]  M. Gimbrone,et al.  Inhibition of E-Selectin Gene Expression by Transforming Growth Factor β in Endothelial Cells Involves Coactivator Integration of Smad and Nuclear Factor κB–Mediated Signals , 2000, The Journal of experimental medicine.

[17]  J. Christman,et al.  The role of nuclear factor-kappa B in cytokine gene regulation. , 1997, American journal of respiratory cell and molecular biology.

[18]  P. Ward,et al.  Acute immunologic pulmonary alveolitis. , 1974, The Journal of clinical investigation.

[19]  D. Goeddel,et al.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. , 1997, Science.

[20]  C. Weber,et al.  Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. , 1993, Journal of immunology.

[21]  A. Malik,et al.  In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. , 1997, Journal of immunology.

[22]  M. Matthay,et al.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. , 1992, The American review of respiratory disease.

[23]  S. McKnight,et al.  Scissors-grip model for DNA recognition by a family of leucine zipper proteins. , 1989, Science.

[24]  R. Umek,et al.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. , 1991, Genes & development.

[25]  G. Courtois,et al.  Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. , 1998, Cell.

[26]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[27]  M. Birrer,et al.  TNF-α Gene Expression in Macrophages: Regulation by NF-κB Is Independent of c-Jun or C/EBPβ1 , 2000, The Journal of Immunology.

[28]  R. Shenkar,et al.  Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta. , 1999, Chest.

[29]  P. Herlevsen,et al.  Antioxidant Treatment with N-Acetylcysteine During Adult Respiratory Distress Syndrome: A Prospective, Randomized, Placebo-Controlled Study , 1993 .

[30]  F. Lee,et al.  Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. , 1999, The Journal of biological chemistry.

[31]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[32]  M. Tsan,et al.  Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. , 1993, Journal of applied physiology.

[33]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[34]  P. Ridgway,et al.  The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome , 1997, The EMBO journal.

[35]  D B Young,et al.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. , 1997, Science.

[36]  P. Ward,et al.  Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury. , 1996, The Journal of clinical investigation.

[37]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.

[38]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[39]  S. Nemoto,et al.  Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase. , 1998, Molecular and cellular biology.

[40]  R. Shenkar,et al.  Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. , 1997, American journal of respiratory cell and molecular biology.

[41]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[42]  P. Ward,et al.  Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. , 1995, American journal of respiratory cell and molecular biology.

[43]  J. Christman,et al.  In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. , 1996, Journal of immunology.

[44]  M. Thomassen,et al.  Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. , 1996, Clinical immunology and immunopathology.

[45]  P. Baeuerle,et al.  Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. , 2000, Free radical biology & medicine.

[46]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[47]  A. Baldwin,et al.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.

[48]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[49]  M. Merika,et al.  Distinct functional properties of IkappaB alpha and IkappaB beta , 1997, Molecular and cellular biology.

[50]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[51]  P. Suter,et al.  N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. , 1994, Chest.

[52]  R. Hay,et al.  Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhinition of NF-ϰB binding activity , 1993 .

[53]  K. Bhatia,et al.  Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. , 1991, Oncogene.

[54]  P. Baeuerle,et al.  IKAP is a scaffold protein of the IκB kinase complex , 1998, Nature.

[55]  M. May,et al.  Signal transduction through NF-kappa B. , 1998, Immunology today.

[56]  P. Baeuerle,et al.  Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb , 2000 .

[57]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[58]  R. Shenkar,et al.  Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. , 1999, Journal of immunology.

[59]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[60]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[61]  L. O’Neill.  Specificity in the innate response: pathogen recognition by Toll-like receptor combinations. , 2001, Trends in immunology.

[62]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[63]  R. Shenkar,et al.  Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. , 1997, The Journal of clinical investigation.

[64]  A. Manning,et al.  Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells* , 1998, The Journal of Biological Chemistry.

[65]  T. Deerinck,et al.  Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.

[66]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[67]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[68]  R. Shenkar,et al.  Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. , 1996, Critical care medicine.

[69]  B. Aggarwal,et al.  Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.

[70]  K. Tracey,et al.  Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation1 , 2000, The Journal of Immunology.

[71]  A. Fowler,et al.  Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. , 1991, The American review of respiratory disease.

[72]  P. Baeuerle,et al.  NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.

[73]  T. Shanley,et al.  Regulation of chemokine expression by IL-10 in lung inflammation. , 2000, Cytokine.

[74]  A. Lentsch,et al.  NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. , 1998, The American journal of pathology.

[75]  A. Lentsch,et al.  Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. , 1999, American journal of respiratory cell and molecular biology.

[76]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[77]  C. Mueller-Dieckmann,et al.  Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. , 1996, Cell.

[78]  R. Cotran,et al.  The role of endothelial cells in inflammation. , 1990, Transplantation.

[79]  I. Verma,et al.  IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.

[80]  Weiliang Tang,et al.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. , 1996, The Journal of clinical investigation.

[81]  Tao Yan,et al.  Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1* , 1998, The Journal of Biological Chemistry.

[82]  A. Sauaia,et al.  Early predictors of postinjury multiple organ failure. , 1994, Archives of surgery.

[83]  C. Scheidereit,et al.  NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. , 1993, Oncogene.

[84]  D. Baltimore,et al.  NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.

[85]  H. Nakano,et al.  Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  A. Lentsch,et al.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.

[87]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[88]  G. Su,et al.  Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll‐like receptor 4 , 2000, Hepatology.

[89]  V. Bours,et al.  The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.

[90]  J. Brickman,et al.  Interactions between an HMG-1 protein and members of the Rel family. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  C. Scheidereit,et al.  NF-kappaB and the innate immune response. , 2000, Current opinion in immunology.

[92]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[93]  M. Mann,et al.  IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex , 1999, Molecular and Cellular Biology.

[94]  A. Israël,et al.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. , 1997, The EMBO journal.

[95]  A. Manning,et al.  Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. , 1995, Agents and actions. Supplements.

[96]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[97]  E. Abraham,et al.  Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. , 1998, Journal of immunology.

[98]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[99]  S. Ghosh,et al.  Signal transduction through NF-κB , 1998 .

[100]  V. Bours,et al.  Lymphocyte activation and the family of NF-kappa B transcription factor complexes. , 1992, Current topics in microbiology and immunology.

[101]  E. Zandi,et al.  The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. , 1997, Cell.

[102]  S. Rhee,et al.  Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible Cyclooxygenase* , 2000, The Journal of Biological Chemistry.

[103]  L Cohen,et al.  IKAP is a scaffold protein of the IkappaB kinase complex. , 1998, Nature.

[104]  T. Standiford,et al.  Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival , 1997, Infection and immunity.

[105]  J. Marshall,et al.  Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. , 2000, American journal of respiratory cell and molecular biology.

[106]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[107]  C. J. Dunn,et al.  NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. , 1995, Journal of Inflammation.

[108]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[109]  E. Faist,et al.  Multiple organ failure in polytrauma patients. , 1983, The Journal of trauma.

[110]  A. Lentsch,et al.  Essential Role of Alveolar Macrophages in Intrapulmonary Activation of NF- κ B , 1999 .

[111]  A. M. Lefer,et al.  Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB. , 1999, Anesthesiology.

[112]  K. Brigham,et al.  Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. , 1981, The Journal of clinical investigation.

[113]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[114]  J. Pittet,et al.  Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. , 1996, The American journal of physiology.

[115]  I. Verma,et al.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.

[116]  R. Shenkar,et al.  Systemic blood loss affects NF‐&kgr;B regulatory mechanisms in the lungs: 74 , 1997 .

[117]  M. Birrer,et al.  TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. , 2000, Journal of immunology.

[118]  J. Christman,et al.  Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kappa B activation. , 1994, American journal of respiratory cell and molecular biology.

[119]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[120]  T. Maniatis,et al.  Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. , 1996, Cell.

[121]  J. Marshall,et al.  Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. , 1998, Journal of immunology.

[122]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[123]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[124]  H. Nakano,et al.  Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 , 1998 .

[125]  M. Burdick,et al.  The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome , 1996, Annals of Internal Medicine.

[126]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[127]  M. Beltrame,et al.  Flexing DNA: HMG-box proteins and their partners. , 1998, American journal of human genetics.

[128]  B. Monks,et al.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.

[129]  P. Baeuerle.  Pro-inflammatory signaling: Last pieces in the NF-κB puzzle? , 1998, Current Biology.

[130]  A. Fishman,et al.  Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI Workshop summary. , 1998, American journal of respiratory and critical care medicine.

[131]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[132]  P. Parsons,et al.  Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. , 1997, American journal of respiratory and critical care medicine.

[133]  S. Akira,et al.  TLR6: A novel member of an expanding toll-like receptor family. , 1999, Gene.

[134]  C. Farver,et al.  Constitutive NF-kappaB levels in human alveolar macrophages from normal volunteers. , 1998, Cytokine.

[135]  G. Downey,et al.  Mechanisms of Neutrophil Mediated Injury , 1996 .

[136]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[137]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[138]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[139]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.

[140]  S. Akira,et al.  IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. , 1999, International immunology.

[141]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[142]  邊見 弘明,et al.  A Toll-like receptor recognizes bacterial DNA , 2003 .

[143]  P. Parsons.  Mediators and mechanisms of acute lung injury. , 2000, Clinics in chest medicine.

[144]  R. Schlapbach,et al.  Oxidants in mitochondria: from physiology to diseases. , 1995, Biochimica et biophysica acta.

[145]  S. R. Himes,et al.  The Role of High-Mobility Group I(Y) Proteins in Expression of IL-2 and T Cell Proliferation1 , 2000, The Journal of Immunology.

[146]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[147]  C. Janeway,et al.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.

[148]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[149]  P. Godowski,et al.  Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. , 2000, Nature immunology.

[150]  R. Strieter,et al.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.

[151]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[152]  E. Chi,et al.  Neutrophil apoptosis in the acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[153]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[154]  A. Malik,et al.  Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. , 1999, Circulation.

[155]  P. Ward,et al.  Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. , 1997, Journal of immunology.

[156]  V. Bours,et al.  The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. , 1993, The EMBO journal.

[157]  H. Petty,et al.  Cutting Edge: Lipopolysaccharide Induces Physical Proximity Between CD14 and Toll-Like Receptor 4 (TLR4) Prior to Nuclear Translocation of NF-κB1 , 2000, The Journal of Immunology.

[158]  A. C. Webb,et al.  Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene , 1994, Molecular and cellular biology.

[159]  F. Luscinskas,et al.  Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.

[160]  P. Ward,et al.  Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. , 1995, Journal of immunology.

[161]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[162]  D. Olive,et al.  The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[163]  M. Mayo,et al.  Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.

[164]  E. Zandi,et al.  A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. , 1997, Nature.

[165]  J. Repine.  Scientific perspectives on adult respiratory distress syndrome , 1992, The Lancet.

[166]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[167]  U. Göbel,et al.  Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-κB Translocation* , 2001, The Journal of Biological Chemistry.

[168]  S. McKnight,et al.  Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. , 1991, Trends in biochemical sciences.

[169]  D. Thomas,et al.  Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. , 1997, Journal of cell science.

[170]  D. Remick,et al.  Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. , 1997, The American journal of pathology.

[171]  A. Lin,et al.  Coordinate Regulation of IκB Kinases by Mitogen-Activated Protein Kinase Kinase Kinase 1 and NF-κB-Inducing Kinase , 1998, Molecular and Cellular Biology.

[172]  H. Petty,et al.  Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. , 2000, Journal of immunology.

[173]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[174]  R. Shenkar,et al.  Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1beta. , 1999, Clinical immunology.

[175]  B. Aggarwal,et al.  Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. , 1996, The Journal of biological chemistry.

[176]  R. Shenkar,et al.  Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[177]  F. Stentz,et al.  Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. , 1995, Chest.

[178]  S. Akira,et al.  Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.

[179]  M. Mayo,et al.  Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.

[180]  R. Hay,et al.  Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity. , 1993, Nucleic Acids Research.

[181]  D. Nathans,et al.  Multivalent DNA-binding properties of the HMG-1 proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[182]  H. Rauvala,et al.  Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.

[183]  E. Moore,et al.  Evolving concepts in the pathogenesis of postinjury multiple organ failure. , 1995, The Surgical clinics of North America.

[184]  A. Malik,et al.  Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. , 1999, Molecular pharmacology.

[185]  J. Downward.  Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.

[186]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[187]  E. Zandi,et al.  IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. , 1998, Nature.

[188]  P. Godowski,et al.  Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway , 2000, Nature Immunology.